Literature DB >> 16271783

Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets.

Aki Tsuchiya1, John Brazier, Jennifer Roberts.   

Abstract

An interview study with 101 members of public compared the protocols used in valuation studies for EQ-5D (using ranking, visual analogue scale, and time trade-off), and SF-6D (using ranking and standard gamble). Respondents were given one of the two protocols and asked to value four states each from EQ-5D and SF-6D. VAS scores suggest the narrower range of SF-6D values is partly attributable to the descriptive system; TTO values for milder states were higher than SG values; and the mean value for EQ-5D pits using TTO and SF-6D pits using SG were closer than across the two original valuation studies.

Entities:  

Mesh:

Year:  2005        PMID: 16271783     DOI: 10.1016/j.jhealeco.2005.09.003

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  31 in total

1.  Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes.

Authors:  Mangala Rajan; Kuan-Chi Lai; Chin-Lin Tseng; Shirley Qian; Alfredo Selim; Lewis Kazis; Leonard Pogach; Anushua Sinha
Journal:  Qual Life Res       Date:  2012-03-06       Impact factor: 4.147

2.  A comparison of the ICECAP-O with EQ-5D in a falls prevention clinical setting: are they complements or substitutes?

Authors:  Jennifer C Davis; Teresa Liu-Ambrose; Chris G Richardson; Stirling Bryan
Journal:  Qual Life Res       Date:  2012-06-22       Impact factor: 4.147

3.  Measuring preferences for cost-utility analysis: how choice of method may influence decision-making.

Authors:  Christine M McDonough; Anna N A Tosteson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

4.  How consistent are health utility values?

Authors:  Pedro L Ferreira; Lara N Ferreira; Luis N Pereira
Journal:  Qual Life Res       Date:  2008-08-08       Impact factor: 4.147

5.  Is it time to update societal value sets for preference-based measures of health?

Authors:  A Simon Pickard
Journal:  Pharmacoeconomics       Date:  2015-03       Impact factor: 4.981

6.  Bayesian Hierarchical Models for Meta-Analysis of Quality-of-Life Outcomes: An Application in Multimorbidity.

Authors:  Susanne Schmitz; Tatjana T Makovski; Roisin Adams; Marjan van den Akker; Saverio Stranges; Maurice P Zeegers
Journal:  Pharmacoeconomics       Date:  2020-01       Impact factor: 4.981

7.  The role of the electronic medical record in the assessment of health related quality of life.

Authors:  Serguei V S Pakhomov; Nilay D Shah; Holly K Van Houten; Penny L Hanson; Steven A Smith
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

8.  Automatic quality of life prediction using electronic medical records.

Authors:  Sergeui Pakhomov; Nilay Shah; Penny Hanson; Saranya Balasubramaniam; Steven A Smith; Steven Allan Smith
Journal:  AMIA Annu Symp Proc       Date:  2008-11-06

9.  Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D.

Authors:  A Szende; N K Leidy; E Ståhl; K Svensson
Journal:  Qual Life Res       Date:  2008-12-23       Impact factor: 4.147

10.  Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain.

Authors:  Garry R Barton; Tracey H Sach; Anthony J Avery; Michael Doherty; Claire Jenkinson; Kenneth R Muir
Journal:  Cost Eff Resour Alloc       Date:  2009-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.